Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-Data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002)

For the North-East Japan Study Group

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-Data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002)'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology

Chemical Engineering